Article

Antibody response against SARS-CoV-2 spike protein in people with HIV after COVID-19 vaccination

2024-06-08

Abstract excerpt

<h4>Background: </h4> People with HIV (PWH) often have a suboptimal response to vaccines, raising concerns about the efficacy of coronavirus disease 2019 (COVID-19) vaccines in this population. We aimed to evaluate the humoral immune response to the B.1 lineage and Omicron variant in PWH following COVID-19 vaccination. <h4>Methods:</h4> We conducted a prospective study on 19 PWH who received a two-dose series of t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 40affd7d-703e-5187-aba7-68e563404e19
DOI: 10.1101/2024.06.07.24308586

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Antibody response against SARS-CoV-2 spike protein in people with HIV after COVID-19 vaccinationDOI 10.1101/2024.06.07.24308586Read

Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-length SARS-CoV-2 Spike Protein Variants in a Population of Black PLWH Vaccinated with ChAdOx1 nCoV-19Semantic proximity Read

Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV-1Semantic proximity Read

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine in People Living with HIV-1Semantic proximity Read

Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIVSemantic proximity Read

COVID-19 Vaccinations, Infections and Outcomes among 784 People Living with HIVSemantic proximity Read

SARS-CoV-2 mRNA Vaccine Induced Immune Responses in Men with HIV-1 and Impact on Proviral ReservoirsSemantic proximity Read

Hybrid immunity improves the immune response after fourth Covid-19 vaccine dose in individuals with medical conditions predisposing to severe Covid-19Semantic proximity Read

Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected personsSemantic proximity Read

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patientsSemantic proximity Read

Vaccination of COVID-19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against SARS-CoV-2 VariantsSemantic proximity Read

Long-Term Safety and Immunogenicity of an MF59-Adjuvanted Spike Glycoprotein-Clamp Vaccine for SARS-CoV-2 in Adults Aged 18–55 Years or ≥56 Years: 12-Month Results from a Randomised, Double-Blind, Placebo-Controlled, Phase 1 TrialSemantic proximity Read

Differences in the concentration of anti-SARS-CoV-2 IgG antibodies post-COVID-19 recovery or post-vaccinationSemantic proximity Read